Hospital Israelita Albert Einstein is Latin America's top-ranked hospital and cancer programme.
Hospital Israelita Albert Einstein in São Paulo is Latin America's top-ranked hospital and cancer programme, placed seventeenth in the Newsweek/Statista World's Best Specialized Hospitals list for oncology. It is the leading Brazilian centre for clinical trials, precision oncology and radiotherapy, and a major Latin American enroller in global phase 3 trials, which gives it outsized influence on how new drugs reach the region. OnCo links it to Rafael Kaliks and Carlos Barrios, to the Brazilian regulator ANVISA, and to the idea of burden-matched funding for trials led in low- and middle-income countries. Whether trial leadership, rather than enrolment alone, can shift to centres like this is the open question. Its trials and precision oncology programmes are the ones to follow.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Hospital Israelita Albert Einstein, including child institutions. 279 works · 1,542 citations · 82% open access · 10% clinical trials · 4% reviews.
Carlos Barrios is the most visible Latin American voice in global breast cancer trials and a founder of the region's cooperative group LACOG.
A São Paulo medical oncologist who has helped shape Einstein's precision oncology and quality programmes.